Breast cancer

3 currently open clinical trials
Palbociclib for patients with hormone receptor positive / HER2-negative breast cancer that has recurred after surgical removal (POLAR)
IBCSG 59-19 POLAR
A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
To reduce the use of Chemotherapy in elderly patients with ER-positive and HER2-positive breast cancer
IBCSG 55-17 TOUCH
All cancer types